Bedi A - Search Results

1

Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA.

Izumchenko E, Chang X, Brait M, Fertig E, Kagohara LT, Bedi A, Marchionni L, Agrawal N, Ravi R, Jones S, Hoque MO, Westra WH, Sidransky D. Izumchenko E, et al. Among authors: bedi a. Nat Commun. 2015 Sep 16;6:8258. doi: 10.1038/ncomms9258. Nat Commun. 2015. PMID: 26374070 Free PMC article.

2

The TGFβ-miR200-MIG6 pathway orchestrates the EMT-associated kinase switch that induces resistance to EGFR inhibitors.

Izumchenko E, Chang X, Michailidi C, Kagohara L, Ravi R, Paz K, Brait M, Hoque MO, Ling S, Bedi A, Sidransky D. Izumchenko E, et al. Among authors: bedi a. Cancer Res. 2014 Jul 15;74(14):3995-4005. doi: 10.1158/0008-5472.CAN-14-0110. Epub 2014 May 15. Cancer Res. 2014. PMID: 24830724 Free PMC article.

3

Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy.

Ravi R, Noonan KA, Pham V, Bedi R, Zhavoronkov A, Ozerov IV, Makarev E, V Artemov A, Wysocki PT, Mehra R, Nimmagadda S, Marchionni L, Sidransky D, Borrello IM, Izumchenko E, Bedi A. Ravi R, et al. Among authors: bedi a, bedi r. Nat Commun. 2018 Feb 21;9(1):741. doi: 10.1038/s41467-017-02696-6. Nat Commun. 2018. PMID: 29467463 Free PMC article.

4

Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L).

Ravi R, Bedi A. Ravi R, et al. Among authors: bedi a. Cancer Res. 2002 Mar 15;62(6):1583-7. Cancer Res. 2002. PMID: 11912124

5

Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.

Ravi R, Bedi A. Ravi R, et al. Among authors: bedi a. Cancer Res. 2002 Aug 1;62(15):4180-5. Cancer Res. 2002. PMID: 12154014

6

Potential methods to circumvent blocks in apoptosis in lymphomas.

Ravi R, Bedi A. Ravi R, et al. Among authors: bedi a. Curr Opin Oncol. 2002 Sep;14(5):490-503. doi: 10.1097/00001622-200209000-00004. Curr Opin Oncol. 2002. PMID: 12192267 Review.

7

NF-kappaB in cancer--a friend turned foe.

Ravi R, Bedi A. Ravi R, et al. Among authors: bedi a. Drug Resist Updat. 2004 Feb;7(1):53-67. doi: 10.1016/j.drup.2004.01.003. Drug Resist Updat. 2004. PMID: 15072771 Review.

8

Regulation of p53 family member isoform DeltaNp63alpha by the nuclear factor-kappaB targeting kinase IkappaB kinase beta.

Chatterjee A, Chang X, Sen T, Ravi R, Bedi A, Sidransky D. Chatterjee A, et al. Among authors: bedi a. Cancer Res. 2010 Feb 15;70(4):1419-29. doi: 10.1158/0008-5472.CAN-09-2613. Epub 2010 Feb 9. Cancer Res. 2010. PMID: 20145131 Free PMC article.

9

Inhibition of TGF-β enhances the in vivo antitumor efficacy of EGF receptor-targeted therapy.

Bedi A, Chang X, Noonan K, Pham V, Bedi R, Fertig EJ, Considine M, Califano JA, Borrello I, Chung CH, Sidransky D, Ravi R. Bedi A, et al. Among authors: bedi r. Mol Cancer Ther. 2012 Nov;11(11):2429-39. doi: 10.1158/1535-7163.MCT-12-0101-T. Epub 2012 Aug 27. Mol Cancer Ther. 2012. PMID: 22927667 Free PMC article.

10

The relative expression of Mig6 and EGFR is associated with resistance to EGFR kinase inhibitors.

Chang X, Izumchenko E, Solis LM, Kim MS, Chatterjee A, Ling S, Monitto CL, Harari PM, Hidalgo M, Goodman SN, Wistuba II, Bedi A, Sidransky D. Chang X, et al. Among authors: bedi a. PLoS One. 2013 Jul 31;8(7):e68966. doi: 10.1371/journal.pone.0068966. Print 2013. PLoS One. 2013. PMID: 23935914 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

586 results

Search Page

Filters